Satish Narayanaswamy Nadig

Medicine & Life Sciences

1. Transplants 100%
2. Liver Transplantation 73%
3. Transplant Recipients 66%
4. Kidney 49%
5. Allografts 42%
6. Transplantation 41%
7. Regulatory T-Lymphocytes 38%
8. Organ Transplantation 36%
9. Tissue Donors 36%
10. Reperfusion Injury 36%
11. Kidney Transplantation 35%
12. Arteriosclerosis 35%
13. Complement Inactivating Agents 24%
14. T-Lymphocytes 22%
15. Pediatrics 22%
16. Immunosuppression 21%
17. Antibodies 19%
18. Heart Valves 17%
19. African Americans 17%
20. Heart Transplantation 16%
21. SARS Virus 15%
22. Brain Death 15%
23. Pancreas Transplantation 15%
24. Liver 15%
25. Graft Survival 14%
26. Medication Adherence 14%
27. Isoantigens 13%
28. Delayed Graft Function 13%
29. Immunosuppressive Agents 13%
30. Tacrolimus 12%
31. Therapeutics 12%
32. Inferior Vena Cava 12%
33. Composite Tissue Allografts 12%
34. Living Donors 11%
35. Pancreas 11%
36. complement C3a receptor 11%
37. Transplantation Tolerance 10%
38. Patient Readmission 10%
39. Nanotechnology 10%
40. Wounds and Injuries 9%
41. Portal Vein 9%
42. Sirolimus 9%
43. Lung 9%
44. Psychology Rejection 9%
45. Rodentia 9%
46. Graft Rejection 9%
47. Nanoparticles 9%
48. Babesia microti 9%
49. Endothelial Cells 8%
50. Technology 8%